Requirements and expectations
UK Clinical Research Inclusion Group Workstream
Problem statement
Researchers and sponsors are not clear what is expected of them when they are asked to consider inclusion for representative clinical research. They, and the reviewers, do not know what good looks like or where to go for help.
Actions for the UK Clinical Research Inclusion Group
- develop a sector-wide agreed definition of research inclusion
- agree a baseline of expectation for research inclusion
- develop a set of sector-wide key performance indicators and metrics on research inclusion, aligned to baseline expectations, to support systemic compliance and drive accountability
- align application questions and supporting guidance between funders and regulators
- identify a core set of guidance, toolkits or checklists, aimed for researchers and sponsors, to be endorsed by the group
Actions for group members
- update guidance, toolkit or checklist for reviewers of funders and regulators so they are aligned to baseline expectations on research inclusion and current national expectations on public involvement in research
Ongoing work
Research inclusion as a condition of NIHR funding
National Institute for Health and Care Research (NIHR)
A requirement introduced in Nov 2024 where applicants need to demonstrate how inclusion is being built into all stages of the research lifecycle.
NIHR sex and gender in research policy was launched in November 2025.
Inclusion and Diversity expectation for CSO-funded research
Chief Scientist Office (CSO) – Scotland
For both of CSO’s funding committees (Translational Clinical Studies Research Committee and Health Improvement, Protection and Services Research Committee), applicants are asked to consider inclusion and diversity in design and apply relevant guidance
Guidance for developing an Inclusion and Diversity Plan
HRA, MHRA
Guidance to support researchers and sponsors to consider and demonstrate how they will include a diverse range of people that is relevant for their trial.
HRA has completed a pilot, where clinical trial sponsors volunteered to develop an Inclusion and Diversity Plan and submit this as part of their application for review by a Research Ethics Committee. This pilot is now being evaluated.
Public statement of support to improve how research accounts for sex and gender dimensions
MESSAGE project (32 signatories)
Signatory organisations stating their commitment to improved integration of sex and gender in biomedical, health and care research.
Statement of intent: Integrating older age into health and care research
NIHR (43 signatories)
Signatory organisations stating their commitment to actively supporting the inclusion of older adults in research, particularly where health conditions have a particular impact on this group.
Joint statement on strengthening clinical trials
WHO (13 signatory research funders including NIHR and Wellcome Trust)
Signatory funders committing to implement WHO standards to strengthen clinical trial systems as outlined in Guidance for best practice for clinical trials including ensuring representative trial populations.